|
|
||||||||




Departments of
* Neurology and
Pulmonary Medicine, University of California, San Francisco, CA 94143;
Department of Neurology, Stanford University, Stanford, CA 94305;
Tularik, South San Francisco, CA 94080;
¶ University of North Carolina, Chapel Hill, NC 27599; and
|| Glaxo SmithKline Pharmaceuticals, King of Prussia, PA 19406; and
# Mercer University School of Medicine, Macon, GA 31207
The role of the MHC class II transactivator (CIITA) in Ag
presentation by astrocytes and susceptibility to experimental
autoimmune encephalomyelitis (EAE) was examined using CIITA-deficient
mice and newly created transgenic mice that used the glial fibrillary
acidic protein promoter to target CIITA expression in
astrocytes. CIITA was required for class II expression on astrocytes.
Like class II-deficient mice, CIITA-deficient mice were resistant to
EAE by immunization with CNS autoantigen, although T cells from
immunized CIITA-deficient, but not class II-deficient, mice
proliferated and secreted Th1 cytokines. CIITA-deficient splenic APC
presented encephalitogenic peptide to purified wild-type
encephalitogenic CD4+ T cells, indicating that
CIITA-independent mechanisms can be used for class II-restricted Ag
presentation in lymphoid tissue. CIITA-deficient mice were also
resistant to EAE by adoptive transfer of encephalitogenic class
II-restricted CD4+ Th1 cells, indicating that
CIITA-dependent class II expression was required for CNS Ag
presentation. Despite constitutive CIITA-driven class II expression on
astrocytes in vivo, glial fibrillary acidic protein-CIITA transgenic
mice were no more susceptible to EAE than controls. CIITA-transfected
astrocytes presented peptide Ag, but in contrast to IFN-
-activated
astrocytes, they could not process and present native Ag.
CIITA-transfected astrocytes did not express cathepsin S without
IFN-
activation, indicating that CIITA does not regulate other
elements that may be required for Ag processing by astrocytes. Although
our results demonstrate that CIITA-directed class II expression is
required for EAE induction, CIITA-directed class II expression by
astrocytes does not appear to increase EAE susceptibility. These
results do not support the role of astrocytes as APC for class
II-restricted Ag presentation during the induction phase of
EAE.
This article has been cited by other articles:
![]() |
W. Hu, S. Nessler, B. Hemmer, T. N. Eagar, L. P. Kane, S. R. Leliveld, A. Muller-Schiffmann, A. R. Gocke, A. Lovett-Racke, L.-H. Ben, et al. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling Brain, February 9, 2010; (2010) awp298v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harnesk, M. Swanberg, J. Ockinger, M. Diez, O. Lidman, E. Wallstrom, A. Lobell, T. Olsson, and F. Piehl Vra4 Congenic Rats with Allelic Differences in the Class II Transactivator Gene Display Altered Susceptibility to Experimental Autoimmune Encephalomyelitis J. Immunol., March 1, 2008; 180(5): 3289 - 3296. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Soualhine, A.-E. Deghmane, J. Sun, K. Mak, A. Talal, Y. Av-Gay, and Z. Hmama Mycobacterium bovis Bacillus Calmette-Guerin Secreting Active Cathepsin S Stimulates Expression of Mature MHC Class II Molecules and Antigen Presentation in Human Macrophages J. Immunol., October 15, 2007; 179(8): 5137 - 5145. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhu, Y. Bando, S. Xiao, K. Yang, A. C. Anderson, V. K. Kuchroo, and S. J. Khoury CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis J. Immunol., October 15, 2007; 179(8): 5228 - 5237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Martinez, M. Sanchez-Lopez, J. Varade, A. Mas, M Carmen Martin, V. de las Heras, R. Arroyo, J. Luis Mendoza, M. Diaz-Rubio, B. Fernandez-Gutierrez, et al. Role of the MHC2TA gene in autoimmune diseases Ann Rheum Dis, March 1, 2007; 66(3): 325 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kimura, M. Kimura, S.-C. Tzou, Y.-C. Chen, K. Suzuki, N. R. Rose, and P. Caturegli Expression of Class II Major Histocompatibility Complex Molecules on Thyrocytes Does Not Cause Spontaneous Thyroiditis but Mildly Increases Its Severity after Immunization Endocrinology, March 1, 2005; 146(3): 1154 - 1162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |